Clinical trials in Liege – page 53

648 clinical trials in Liege, Belgium across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Liege at a glance

648

clinical trials

Research sites5

Quick filters

648 trials in Liege

Open in trial search

Ovarian epithelial cancer

Not recruiting

Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

Registered drug

Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Ischaemic stroke

Not recruiting

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Tenecteplase
Sponsor:Insel Gruppe AG

Contact Research Centre

Dry age-related macular degeneration

Not recruiting

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Prednisone
Sponsor:Janssen Cilag International

Contact Research Centre

Colitis ulcerative

Not recruiting

Study on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

Study on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:ABBV-668
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Thermal burn

Not recruiting

Study on the Effects of High-Dose Vitamin C in Patients with Severe Burns

Registered drug

Study on the Effects of High-Dose Vitamin C in Patients with Severe Burns

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Ascorbic Acid
Sponsor:Queen's University

Contact Research Centre

Endometrial cancer

Not recruiting

Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

Registered drugNo placebo

Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:GEN1046
Sponsor:Genmab A/S

Contact Research Centre

Colorectal cancer metastatic+1

Not recruiting

Study on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer

Registered drug

Study on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Inspirna Inc.

Contact Research Centre

Acute coronary syndrome

Not recruiting

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Janssen Cilag International

Contact Research Centre

Endometrial cancer

Not recruiting

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Febrile neutropenia

Not recruiting

Study on Shortening Antibiotic Treatment for Febrile Neutropenia in Hematology Patients Using Cefepime and Drug Combination

Registered drugNo placebo

Study on Shortening Antibiotic Treatment for Febrile Neutropenia in Hematology Patients Using Cefepime and Drug Combination

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cefepime
Sponsor:UZ Leuven

Contact Research Centre

Diffuse large B-cell lymphoma+1

Not recruiting

Study on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients

Registered drugNo placebo

Study on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Liege

What the registry says about research in the country

01 Infectious Disease Research

Groundbreaking vaccine trials focusing on chickenpox, cytomegalovirus, and respiratory syncytial virus. These studies aim to evaluate immune responses and develop effective prevention strategies for vulnerable populations.

Varicella vaccine safety in children
CMV prevention in young adults
RSV protection in transplant recipients

02 Oncology Studies

Advanced research into various cancer treatments, particularly focusing on lung cancer and gastric cancer. Trials evaluate novel therapeutic combinations and targeted treatments for improved patient outcomes.

Non-small cell lung cancer therapies
Hematological cancer treatments
Advanced breast cancer interventions

03 Autoimmune Conditions

Innovative trials investigating treatments for inflammatory bowel disease, psoriasis, and chronic inflammatory conditions. Research focuses on developing targeted therapies and understanding disease mechanisms.

IBD pain management studies
Plaque psoriasis treatments
Inflammatory polyneuropathy therapies

Back to Belgium All countries